Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. AMS
AMS logo

AMS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy American Shared Hospital Services (AMS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.110
1 Day change
-0.94%
52 Week Range
3.110
Analysis Updated At
2026/03/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

American Shared Hospital Services (AMS) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. The stock lacks significant positive catalysts, has weak financial performance, and shows no clear technical or proprietary trading signals to suggest a strong entry point. Holding or exploring other opportunities may be more prudent.

Technical Analysis

The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, the RSI is neutral at 37.287, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 2.119, with resistance at 2.174 and support at 2.064.

Positive Catalysts

  • The company's gross margin increased by 13.03% YoY in Q3 2025, indicating some operational efficiency improvement.

Neutral/Negative Catalysts

  • Net income dropped significantly by -91.79% YoY, and EPS fell to 0 (-100% YoY). Additionally, there is no recent news, no significant trading trends from hedge funds or insiders, and no recent congress trading data.

Financial Performance

In Q3 2025, revenue increased by 2.46% YoY to $7,171,000. However, net income dropped to -$17,000 (-91.79% YoY), and EPS fell to 0 (-100% YoY). Gross margin improved to 22.12%, up 13.03% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available on analyst ratings or price target changes.

Wall Street analysts forecast AMS stock price to rise
Analyst Rating
0
Wall Street analysts forecast AMS stock price to rise
Buy
Hold
Sell
0
Current: 2.130
sliders
Low
0
Averages
0
High
0
0
Current: 2.130
sliders
Low
0
Averages
0
High
0
JPMorgan
Overweight
to
NULL
downgrade
AI Analysis
2025-12-04
Reason
JPMorgan
Price Target
AI Analysis
2025-12-04
downgrade
Overweight
to
NULL
Reason
JPMorgan lowered the firm's price target on Amadeus IT Group to EUR 71 from EUR 75 and keeps an Overweight rating on the shares.

People Also Watch